In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.
New U.S. law will require pediatric cancer clinic trials.
In May, the U.S. Preventive Services Task Force recommended against screening for thyroid cancer. After reviewing the available evidence, the task force concluded…
The FDA finds that many so-called laboratory-derived tests may actually harm patients.
Most patients with chronic myeloid leukemia (CML) can live out their normal lives by taking tyrosine kinase inhibitors (TKIs). But mounting evidence also shows that roughly a third of those patients can eventually go off treatment altogether without their disease resurging.
Once considered an inconsequential illness, Zika is now linked with serious health effects including microcephaly and Guillain-Barré syndrome. As the virus makes its way northward, U.S. public health agencies are doing their best to prepare.